— Z-1018 demonstrates comparable antibody and CD4+ T-cell responses to Shingrix®with a favorable tolerability profile — Newly presented data outline robust polyfunctional CD4+ T-cell responses in Z-1018 arms — Company initiates Part 2 of Phase 1/2 head-to-head versus Shingrix in adults 70 years and older Dynavax Technologies Corporation(Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and […]

Axon (Nasdaq: AXON), the global public safety technology leader, today announced that it will report third quarter 2025 financial results after the market closes on Tuesday, November 4, 2025. Axon will host a live Zoom video webinar to discuss the company's financial results at 5 p.m. ET that same day. https://mma.prnewswire.com/media/231466/axon_logo.jpg The live webinar to

CarParts.com, Inc.(NASDAQ: PRTS) will hold a conference call on Tuesday, November 11, 2025 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its financial results for the third quarter ended September 27, 2025. The results will be reported in a press release prior to the call. https://mma.prnewswire.com/media/2449535/Carparts_logo.jpg CarParts.com, Inc. CEO David Meniane and

Conference call at 3:30 p.m. Central time today on ti.com/ir Texas Instruments Incorporated (TI) (Nasdaq: TXN) today reported third quarter revenue of $4.74 billion, net income of $1.36 billion and earnings per share of $1.48.Earnings per share included a 10-cent reduction that was not in the company's original guidance. Regarding the company's performance and returns

JACKSONVILLE, FL / ACCESS Newswire / October 21, 2025 / FRP Holdings, Inc. (NASDAQ:FRPH) announced today that the Company has completed the closing on its Purchase and Sales Agreement to acquire the business operations and development pipeline of Altman Logistics Properties, LLC, an operating platform of BBX Capital. Altman Logistics holds minority interests in a

RAPT Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire October 21, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that it has

(NASDAQ:TRST), Executive Snapshot: Financial results: Key metrics for the third quarter 2025 compared to the third quarter of 2024: Net income of $16.3 million, or $0.86 diluted earnings per share, increased 26.3% compared to $12.9 million, or $0.68 diluted earnings per share Net interest margin of 2.79%, up 18 basis points from 2.61% Return on

(NASDAQ:MU), BOISE, Idaho, Oct. 21, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced that Richard M. Beyer and Mary Pat McCarthy have informed the company that they will retire from its board of directors at the annual shareholders meeting expected to be held on Jan. 15, 2026. Beyer has served on the

(NasdaqGM:RYTM), BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 4, 2025 to report its third

Micron Announces Board of Directors Retirements GlobeNewswire October 21, 2025 BOISE, Idaho, Oct. 21, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced that Richard M. Beyer and Mary Pat McCarthy have informed the company that they will retire from its board of directors at the annual shareholders meeting expected to be held